Neurones SA
PAR:NRO

Watchlist Manager
Neurones SA Logo
Neurones SA
PAR:NRO
Watchlist
Price: 44.2 EUR 1.38% Market Closed
Market Cap: 1.1B EUR
Have any thoughts about
Neurones SA?
Write Note
Section:
 

Relative Value

The Relative Value of one NRO stock under the Base Case scenario is 40.85 EUR. Compared to the current market price of 44.2 EUR, Neurones SA is Overvalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NRO Relative Value
Base Case
40.85 EUR
Overvaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.4
P/S
P/S
Price to Sales
1.4
vs History
26
vs Industry
59
Median 3Y
1.4
Median 5Y
1.4
Industry
2.4
Forward
1.3
More Details
22.1
P/E
P/E
Price to Earnings
22.1
vs History
14
vs Industry
31
Median 3Y
21.7
Median 5Y
20.9
Industry
23.2
Forward
20.9
More Details
17.3
P/OCF
P/OCF
Price to OCF
17.3
vs History
9
vs Industry
37
Median 3Y
16
Median 5Y
12.8
Industry
17.4
More Details
27.1
P/FCFE
P/FCFE
Price to FCFE
27.1
vs History
3
vs Industry
28
Median 3Y
22.8
Median 5Y
16.2
Industry
21.3
More Details
3.1
P/B
P/B
Price to Book Value
3.1
vs History
3
vs Industry
38
Median 3Y
2.9
Median 5Y
2.8
Industry
2.9
More Details
1.1
EV/S
EV/S
Enterprise Value to Sales
1.1
vs History
6
vs Industry
63
Median 3Y
1
Median 5Y
0.9
Industry
2.4
Forward
1
More Details
1.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.1
vs History
12
vs Industry
81
Median 3Y
1.1
Median 5Y
1
Industry
4.9
More Details
9.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
9.3
vs History
1
vs Industry
40
Median 3Y
7.8
Median 5Y
6.7
Industry
12.9
Forward
8.6
More Details
11.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
11.5
vs History
1
vs Industry
38
Median 3Y
9.7
Median 5Y
8.2
Industry
16.5
Forward
10.5
More Details
13.6
EV/OCF
EV/OCF
Enterprise Value to OCF
13.6
vs History
4
vs Industry
42
Median 3Y
10.2
Median 5Y
8.4
Industry
16.3
More Details
19.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
19.7
vs History
1
vs Industry
33
Median 3Y
11.9
Median 5Y
10.3
Industry
19
More Details
2.3
EV/IC
EV/IC
Enterprise Value to IC
2.3
vs History
25
vs Industry
40
Median 3Y
2.4
Median 5Y
2.2
Industry
2.5
More Details

Multiples Across Competitors

NRO Competitors Multiples
Neurones SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Neurones SA
PAR:NRO
1.1B EUR 1.4 22.1 9.3 11.5
IE
Accenture PLC
NYSE:ACN
224.4B USD 3.4 29.6 17.7 21.5
US
International Business Machines Corp
NYSE:IBM
205.2B USD 3.3 32.1 17.8 27
IN
Tata Consultancy Services Ltd
NSE:TCS
15T INR 6 31.7 21.8 23.6
IN
Infosys Ltd
NSE:INFY
8T INR 5.1 29.6 20.8 23.8
IN
HCL Technologies Ltd
NSE:HCLTECH
5.2T INR 4.5 30.7 20 24.1
US
Cognizant Technology Solutions Corp
NASDAQ:CTSH
39.2B USD 2 17.4 12.8 12.8
IN
Wipro Ltd
NSE:WIPRO
3.2T INR 3.6 27.4 16.3 20
US
Gartner Inc
NYSE:IT
37.8B USD 6.2 35.5 28.5 33.5
JP
Fujitsu Ltd
TSE:6702
5.1T JPY 1.4 20.4 13.8 28.4
FR
Capgemini SE
PAR:CAP
26.8B EUR 1.2 15.8 8.9 11.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Neurones SA
PAR:NRO
Average EV/EBITDA: 17.1
9.3
N/A N/A
IE
Accenture PLC
NYSE:ACN
17.7
28%
0.6
US
International Business Machines Corp
NYSE:IBM
17.8
36%
0.5
IN
Tata Consultancy Services Ltd
NSE:TCS
21.8
33%
0.7
IN
Infosys Ltd
NSE:INFY
20.8
34%
0.6
IN
HCL Technologies Ltd
NSE:HCLTECH
20
32%
0.6
US
Cognizant Technology Solutions Corp
NASDAQ:CTSH
12.8
18%
0.7
IN
Wipro Ltd
NSE:WIPRO
16.3
24%
0.7
US
Gartner Inc
NYSE:IT
28.5
42%
0.7
JP
Fujitsu Ltd
TSE:6702
13.8
27%
0.5
FR
Capgemini SE
PAR:CAP
8.9
17%
0.5

See Also

Summary
NRO intrinsic value, competitors valuation, and company profile.
DCF Valuation
NRO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NRO stock valuation using valuation multiples.
Wall Street Estimates
NRO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NRO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.